Sources | Names Used |
---|---|
CTRPv2 | YL54 |
PharmacoGx | YL54 |
Database | Identifier |
---|---|
Smiles: | CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CCNC(C)=O)C(=O)N[C@]1(C)CCCC=C/CCC[C@@](C)(NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SOCS4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PCDHA7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | NEBL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | HADHB | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | PCSK1N | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | FBXL14 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | OR13C2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | DENND4A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | TXNDC9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |